Every Form 4 that IperionX Limited (IPX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IPX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IPX filings page.
IPERIONX Ltd director Beverly Wyse exercised options to acquire 106,093 IPX Ordinary Shares at 0.8700 in Australian dollars per share that were exercisable until December 5, 2026. After the exercise she directly holds 745,868 ordinary shares plus 84,771 RSUs, with 70,609 vesting in December 2026 and 14,162 in December 2027; no open‑market sale is reported.
IPERIONX Ltd director R Tony Tripeny bought 3,846 American Depository Shares (ADS) on July 14, 2026 at $26 per ADS in an open-market purchase. After the trade, he directly holds 8,033 ADS, 51,010 Restricted Stock Units and 38,777 IPX ordinary shares.
IPERIONX Ltd director Lorraine M. Martin purchased 4,100 American Depository Shares (ADS) of IPX at $24.51 per ADS in an open-market transaction on July 10, 2026. Following the trade, she holds 8,855 ADS, 1,177,138 ordinary shares and 90,216 RSUs, with 76,054 RSUs vesting in December 2026 and 14,162 in December 2027. Each ADS is equivalent to 10 ordinary shares.
IPERIONX Ltd President Toby Edgcumbe Symonds reported an open-market purchase of 2,040 American Depository Shares (ADS) of IPX at $24.55 per ADS, representing 20,400 Ordinary Shares. Following this trade, he holds 39,040 ADS, equivalent to 390,400 Ordinary Shares, plus 3,128,089 IPX Ordinary Shares directly. He also holds 703,199 RSUs and a substantial package of options and performance rights over additional Ordinary Shares at exercise prices between A$4 and A$22, with expirations between 2028 and 2031.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reported an open-market purchase of 138,720 IPX Ordinary Shares on July 10, 2026 at an average price of A$3.5844 per share, bringing his directly held Ordinary Shares to 12,455,502. He also directly holds 738,576 Restricted Stock Units, multiple option and performance-right awards over Ordinary Shares at exercise prices between A$6 and A$22, and 128,000 American Depository Shares (ADS), each ADS representing ten Ordinary Shares.
IPERIONX Ltd Executive Chairman Todd Hannigan reported open-market purchases of IPX Ordinary Shares. He bought 225,000 shares on July 10, 2026 at an average price of $3.5786 per share and 300,000 shares on July 13, 2026 at $3.5866 per share, for total recent purchases of 525,000 shares. Following these transactions, he directly holds 26,633,334 Ordinary Shares, along with 454,464 RSUs, 500,000 ADS (each ADS convertible into 10 Ordinary Shares), and various options and performance rights over additional Ordinary Shares.
IPERIONX Ltd President Toby Symonds purchased 3,000 American Depository Shares (ADS) in an open-market transaction at $30.63 per ADS on April 28, 2026, increasing his direct ADS holdings to 37,000 ADS.
Each ADS represents ten ordinary shares, which trade on the ASX, while the ADS trade on Nasdaq. As of this filing, he also directly owns 3,128,089 ordinary shares and holds sizeable option and performance-right positions over additional ordinary shares at exercise prices between A$4 and A$22.
IPERIONX Ltd Chief Financial Officer Marcela Rocha Castro reported new equity awards and updated holdings. On April 2, 2026, she received 52,258 Restricted Stock Units (RSUs) at A$0.00 per unit as part of her annual bonus. These RSUs are scheduled to vest in tranches, including 52,258 vesting in April 2029.
On the same date, she was also granted 127,993 options with an exercise price of A$11.00 per share, likewise described as part of her annual bonus. Each option gives the right to purchase one ordinary share.
After these awards, she directly holds 380,841 ordinary shares, 214,259 RSUs, and options over ordinary shares, including options linked to 216,672 underlying shares at an exercise price of A$5.00 expiring in 2029 and the new 127,993 options at A$11.00 exercisable from 2029 and expiring in 2030. Ordinary shares are traded on the Australian Stock Exchange.
IPERIONX Ltd director Lorraine M. Martin bought 4,755 American Depository Shares (ADS) in an open-market purchase. The ADS were acquired at an average price of $31.4647 per ADS, and each ADS is equivalent to ten Ordinary Shares, or 47,550 Ordinary Shares in total.
After this transaction, Martin directly holds 4,755 ADS, 1,177,138 Ordinary Shares traded on the ASX, and 90,216 Restricted Stock Units (RSUs). According to the filing, 76,054 RSUs vest in December 2026 and 14,162 RSUs vest in December 2027, reflecting a sizable ongoing equity stake tied to future performance and service.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reported an open-market purchase of 110,000 Ordinary Shares on April 28, 2026 at an average price of $4.4875 per share. Following this transaction, he directly holds 12,316,782 Ordinary Shares.
He also reports various equity incentives, including options over 639,205 Ordinary Shares at A$22 and 564,759 Ordinary Shares at A$18, plus multiple performance rights series and 128,000 American Depository Shares, each ADS being exchangeable into ten Ordinary Shares.
IPERIONX Ltd Executive Chairman Todd Hannigan reported significant open-market share purchases. On April 28, 2026, he bought 220,000 Ordinary Shares at an average price of $4.4819 per share, followed by another purchase of 260,000 Ordinary Shares at $4.1991 per share on April 29, 2026.
After these trades, he directly holds 26,108,334 Ordinary Shares, along with 454,464 Restricted Stock Units, 500,000 American Depository Shares, and several option and performance rights awards over additional Ordinary Shares. One ADS is exchangeable for 10 Ordinary Shares, highlighting a substantial overall equity exposure.
IPERIONX Ltd Chief Financial Officer Marcela Rocha Castro received new equity awards. She was granted options over 127,993 IPX Ordinary Shares at an exercise price of A$11 per share and 52,258 restricted stock units, both dated April 2, 2026.
Each option allows the purchase of one ordinary share at the stated conversion price. Following these awards, she directly holds 340,795 ordinary shares and 214,259 restricted stock units. Existing options with a conversion price of A$5 over IPX Ordinary Shares remain outstanding, and the restricted stock units vest on a schedule extending to April 2029.
IPERIONX Ltd President Toby Edgcumbe Symonds reported new equity awards and updated holdings. He received 226,047 performance rights tied to an A$18 share price hurdle and service conditions, plus 536,521 options at A$18 and 607,244 options at A$22, each over IPX ordinary shares. These are compensation-related grants, not market purchases or sales. After these awards, he reports direct ownership of 3,188,146 ordinary shares, 110,000 American Depositary Shares, and substantial additional performance rights and restricted stock units that may convert into ordinary shares if their conditions are met.
Arima Anastasios reported acquisition or exercise transactions in this Form 4 filing.
IPERIONX Ltd Chief Executive Officer Anastasios Arima received multiple new equity awards. On 2026-04-02, he was granted 237,944 performance rights tied to an A$18.00 stock-price hurdle and four years of continuous service, each convertible into one ordinary share once the performance criteria are met.
He was also granted options over 564,759 IPX ordinary shares at A$18.00 and 639,205 shares at A$22.00, each exercisable from 2030-04-02 and expiring on 2031-04-02. These are compensation-related awards, not open-market share purchases or sales.
Following these grants, Arima holds 12,206,782 ordinary shares directly, 128,000 American Depository Shares listed on Nasdaq (each equal to ten ordinary shares), 435,806 performance rights at each of A$6.00, A$7.00 and A$8.00, and 738,576 restricted stock units.
IPERIONX Ltd Executive Chairman Todd Hannigan received new equity awards in the form of performance rights and options linked to IPX Ordinary Shares. On April 2, 2026, he was granted 196,086 performance rights and 465,410 options each with an exercise price of A$18.00, plus 526,760 options with an exercise price of A$22.00.
Each performance right can convert into one ordinary share if service and stock price performance conditions are met, and each option allows purchase of one ordinary share at the stated price. Following these awards, he holds 25,628,334 Ordinary Shares directly, alongside existing derivative positions and 500,000 ADS representing IPX Ordinary Shares.
IPERIONX Ltd President Toby Edgcumbe Symonds made an open‑market purchase of 11,000 American Depository Shares (ADS) of IPERIONX at an average price of $23.8684 per ADS. Each ADS represents 10 ordinary shares traded on the Australian Stock Exchange.
After this transaction, he directly holds 11,000 ADS, 3,188,146 ordinary shares, and 703,199 Restricted Stock Units. He also holds performance rights over ordinary shares with exercise prices of A$4, A$6, A$7 and A$8, exercisable or expiring between December 2028 and April 2030.
IPERIONX Ltd director R. Tony Tripeny bought shares on the open market. He purchased 4,187 American Depository Shares at an average price of $23.7554 per ADS in an open‑market transaction. Following this purchase, he directly holds 4,187 ADS, 38,777 ordinary shares, and 51,010 restricted stock units. One ADS is convertible into 10 ordinary shares, and the RSUs are scheduled to vest in tranches of 36,848 in December 2026 and 14,162 in December 2027.
IPERIONX Ltd director Hannigan Todd made an open-market purchase of 225,225 Ordinary Shares at $3.2009 per share. After this transaction, he directly holds 25,628,334 Ordinary Shares.
He also holds performance rights over 306,302 underlying Ordinary Shares at each of A$6, A$7 and A$8 exercise prices, plus 454,464 Restricted Stock Units and 50,000 American Depository Shares, where each ADS is convertible into 10 Ordinary Shares.
IPERIONX Ltd Chief Executive Officer Arima Anastasios reported significant open-market share purchases. On March 27, 2026, he bought 467,000 Ordinary Shares at an average price of A$3.198, taking his direct Ordinary Share holdings to 12,206,782.
On the same date, he also bought 12,800 American Depository Shares (ADS) at an average price of $23.4097, and now holds 12,800 ADS directly. Each ADS represents 10 Ordinary Shares.
He also holds Performance Rights over 435,806 underlying Ordinary Shares at each of A$6, A$7, and A$8, all expiring on April 10, 2030, plus 738,576 Restricted Stock Units, with 318,666 vesting in December 2026 and 419,910 in April 2028.